Search Results - "Medina, Benjamin D"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    Rethinking T Cells in Pancreas Cancer by Medina, Benjamin D, Miller, George

    Published in Clinical cancer research (01-07-2019)
    “…Patients with pancreatic ductal adenocarcinoma do not benefit from checkpoint blockade. However, human tumors harbor evidence of adaptive immunity in clonally…”
    Get full text
    Journal Article
  3. 3

    Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor by Vitiello, Gerardo A, Bowler, Timothy G, Liu, Mengyuan, Medina, Benjamin D, Zhang, Jennifer Q, Param, Nesteene J, Loo, Jennifer K, Goldfeder, Rachel L, Chibon, Frederic, Rossi, Ferdinand, Zeng, Shan, DeMatteo, Ronald P

    Published in The Journal of clinical investigation (01-05-2019)
    “…Gastrointestinal stromal tumor (GIST) is the most common human sarcoma, frequently characterized by an oncogenic mutation in the KIT or platelet-derived growth…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy by Medina, Benjamin D., Choi, Beatrix Hyemin, Rodogiannis, Kathy G., Moran, Una, Shapiro, Richard L., Pavlick, Anna, Osman, Iman, Berman, Russell S., Lee, Ann Y.

    Published in Journal of surgical oncology (01-09-2020)
    “…Background and Objectives Metastasectomy for melanoma provides durable disease control in carefully selected patients. Similarly, BRAF‐targeted and immune…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Tyrosine Kinase Inhibition Activates Intratumoral γδ T Cells in Gastrointestinal Stromal Tumor by Etherington, Mark S, Hanna, Andrew N, Medina, Benjamin D, Liu, Mengyuan, Tieniber, Andrew D, Kwak, Hyunjee V, Tardy, Katherine J, Levin, Lillian, Do, Kevin J, Rossi, Ferdinando, Zeng, Shan, DeMatteo, Ronald P

    Published in Cancer immunology research (03-01-2024)
    “…γδ T cells are a rare but potent subset of T cells with pleiotropic functions. They commonly reside within tumors but the response of γδ T cells to tyrosine…”
    Get more information
    Journal Article
  14. 14

    Oncogenic KIT Modulates Type I IFN-Mediated Antitumor Immunity in GIST by Liu, Mengyuan, Etherington, Mark S, Hanna, Andrew, Medina, Benjamin D, Vitiello, Gerardo A, Bowler, Timothy G, Param, Nesteene J, Levin, Lillian, Rossi, Ferdinand, DeMatteo, Ronald P

    Published in Cancer immunology research (01-05-2021)
    “…Type I IFNs are implicated in tumor immunogenicity and response to systemic therapy, but their interaction with oncogene signaling is not well understood…”
    Get more information
    Journal Article
  15. 15

    Tyrosine Kinase Inhibition Alters Intratumoral CD8+ T-cell Subtype Composition and Activity by Tieniber, Andrew D, Hanna, Andrew N, Medina, Benjamin D, Vitiello, Gerardo A, Etherington, Mark S, Liu, Mengyuan, Do, Kevin J, Rossi, Ferdinando, DeMatteo, Ronald P

    Published in Cancer immunology research (04-10-2022)
    “…Targeted therapy with a tyrosine kinase inhibitor (TKI) such as imatinib is effective in treating gastrointestinal stromal tumor (GIST), but it is rarely…”
    Get more information
    Journal Article
  16. 16
  17. 17